pirtobrutinib as a bridge to car-t therapy in b-cell malignancies
Published 16 hours ago • 18 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
2:57
strategies to optimize car-t therapy in myeloma: bringing car-t into earlier lines
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
2:36
managing car-t therapy-related aes & treatment options for patients who progress after car-t therapy
-
1:38
challenges of car-t therapy in the real-world setting
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
16:43
engineering better car t cells: an interview with cri star yvonne chen, phd
-
15:22
improving car-t cell therapies (immunotherapy documentary part iii)
-
1:01:36
deciphering car-t cells: exploring functional mechanisms to drive next generation immunotherapy
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
3:22
dealing with the rapid progress in car-t therapies
-
1:50
updates on the use of car-t therapy in mcl
-
9:58
the management & optimization of car t-cell therapy in myeloma
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
4:44
optimizing lymphodepletion chemotherapy in car-t therapy recipients
-
3:47
update on the guidelines for the diagnosis, grading & management of icaht following car-t therapy
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
6:59
management strategies for early and late infections in patients undergoing car-t cell therapy
-
2:33
promising strategies to optimize car-t therapy in all
-
5:25
how to optimize car-t therapy for all
-
0:55
managing crs after car-t therapy
-
0:59
the clinical implementation of car t-cell therapy
-
3:49
strategies to improve cost & access to car-t therapy